60 seconds with… Christophe Suizdak, Cytiva


Ahead of LogiPharma 2021, we spoke to Christophe Suizdak, VP Supply Chain, Cytiva, to discuss how his role has changed in the wake of COVID-19, developments in drug development and more.

How has COVID-19 changed your role and the demands on your team?

A huge workload increase due to the peak in demand. 2021 is following the same trend so far.

Do you think it's possible that this crisis has indirectly sparked any positive change in the industry?

Healthcare capacity was and is still increased across the world. The way new drugs are developed has taken a turn with COVID-19, and it is showing us the path for the future in this regard.

Tell us about your involvement with LogiPharma this year

I was contacted by LogiPharma team to join event as speaker or panel discussion.

Register to attend LogiPharma Virtual Event, 20 - 22 April, 2021

Subscribe to the Free LogiPharma Newsletter

Thanks for signing up! We'll let you know whenever a new article is published.

We respect your privacy, by clicking 'Submit' you will receive our e-newsletter, including information on Webinars, event discounts, online learning opportunities and agree to our User Agreement. You have the right to object. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here.

Return to Blog